iShares TIPS Bond ETF vs Tilray Brands Inc — how do they compare? iShares TIPS Bond ETF trades at $106.81, while Tilray Brands Inc trades at $4.2 (market cap $591.60M). Which is the better fit depends on your goals.
| TIP | TLRY | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $112.20 | $21.00 |
52-Week Low | $106.77 | $3.88 |
Market Cap | — | $591.60M |
Enterprise Value | — | $758.73M |
Signals from Pluang's Aura AI — not financial advice
TIP trades at $107.05 with minimal daily movement (+0.07%). Technical indicators show a bearish trend with moving averages signaling caution, though oscillators are neutral. The stock faces support and resistance clustered around $107. Recent dividend announcements for H2-2026 provide income visibility, but key financial ratios remain undisclosed in current data.
Outlook is cautious amid bearish technicals and lack of fresh fundamental data. Risks include market volatility from inflation and rate concerns highlighted in recent news. Investors should await earnings or SEC filings for updated financial health assessment before considering position changes.
TLRY trades at $4.30, down 4.44% today, with a bearish technical outlook despite trading below book value. The company reported record fiscal 2026 revenue of $821M but posted a substantial $2.19B net loss, with negative cash flow from operations. Recent developments include distribution expansions for Breckenridge Distillery and medical cannabis production increases in Europe.
The stock faces significant fundamental challenges with persistent losses and negative margins, though analyst consensus leans neutral with 65% hold ratings. Key risks include regulatory uncertainty and execution challenges, while potential catalysts include U.S. cannabis reform and international medical expansion.
Trailing returns across standard periods
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →